Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GARAVENTA X3 INCLINED PLATFORM LIFT

K-Number: K122206 · 2013-03-21

ApplicantGaraventa (Canada) Ltd [Dba Garaventa Lift]
Decision Date2013-03-21
Product CodePCE
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

GARAVENTA X3 INCLINED PLATFORM LIFT is the device name listed in this FDA 510(k) record. The listed applicant is Garaventa (Canada) Ltd [Dba Garaventa Lift]. It received FDA 510(k) clearance on 2013-03-21 under 510(k) number K122206. The device is classified under product code PCE. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GARAVENTA X3 INCLINED PLATFORM LIFT?

GARAVENTA X3 INCLINED PLATFORM LIFT is a medical device that received FDA 510(k) clearance on 2013-03-21. The listed applicant is Garaventa (Canada) Ltd [Dba Garaventa Lift]. The 510(k) number is K122206.

When did GARAVENTA X3 INCLINED PLATFORM LIFT receive FDA 510(k) clearance?

GARAVENTA X3 INCLINED PLATFORM LIFT received FDA 510(k) clearance on 2013-03-21, under 510(k) number K122206.

Who is the listed applicant for GARAVENTA X3 INCLINED PLATFORM LIFT?

The FDA 510(k) record lists Garaventa (Canada) Ltd [Dba Garaventa Lift] as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for GARAVENTA X3 INCLINED PLATFORM LIFT?

The FDA product code for GARAVENTA X3 INCLINED PLATFORM LIFT is PCE.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑